Nurse Left ‘Traumatised' After Being Told Trans Colleague Would Be Part of Hysterectomy Team
A nurse involved in a dispute with a transgender-identifying colleague has spoken out about the trauma she experienced after being told the man would be part of the surgical team for her hysterectomy.
Karen Danson said she was left 'traumatised' after the behaviour of the transgender colleague, known as Rose Henderson, brought back memories of the childhood sexual abuse she said she suffered at the hands of her father.
Danson is one of eight women, known as the 'Darlington nurses,' who are taking legal action against County Durham and Darlington NHS Foundation Trust, after they were forced to share a changing room with the male nurse who said he identifies as a woman, despite outwardly presenting as a man.
Speaking through the charity Christian Concern, Danson, 45, said that through 'an unhappy coincidence,' she was due to have a hysterectomy at her workplace, the Darlington Memorial Hospital, last August, just two months after the legal dispute hit the headlines.
She discovered that Henderson was scheduled to be involved in her operation as a surgical assistant.
Danson said, 'I immediately knew this was ethically wrong and that my condition would be made worse and more painful with the stress it would cause.'
Related Stories
2/11/2025
5/5/2025
She approached the theatre manager and explained the situation, the legal case, and how Henderson's involvement would be 'completely inappropriate,' adding that she wanted a woman as the theatre nurse owing to her childhood trauma.
Danson said she was told, 'But Rose is a woman,' and was then accused of being prejudiced and told to take Henderson's feelings into consideration.
The theatre manager told Danson in writing that her request could not be accommodated 'due to clinical and staffing skill mix issues,' and suggested she should either try to get the operation done elsewhere or accept Henderson's presence.
'I believed this was purely vindictive and demonstrated how low they were prepared to go,' Danson said. 'Gender identity was placed above patient and staff care. They tried to punish me for the legal case I was part of and for opposing gender identity policy within the hospital.'
Just days before the operation, Danson went to the Patient Advisory and Liaison Service, which swiftly decided that it would be inappropriate for Henderson to be involved in her surgery.
The legal case is still proceeding to tribunal, despite last month's Supreme Court ruling on the definition of a woman for the purposes of the Equality Act, which means that a trans-identifying biological male does not have the right to access women's changing rooms or toilets.
Danson and the other female nurses are being supported by the Christian Legal Centre, which has said the case 'demonstrates how far the NHS has been prepared to go to uphold gender identity ideology and compromise the basic safety and dignity of female staff and patients.'
The high-profile legal case began a year ago after the women were told by NHS bosses they were being 'transphobic' by objecting to a male in their changing rooms, and advised to 'broaden their mindset' and 're-educate' themselves.
The Darlington nurses photographed outside of Parliament, where they took a petition supporting their right to dignity in the workplace, in an undated file photo.
Christian Concern
On Sunday, Danson, who has been a nurse for six years, revealed that her discomfort at being forced to change with a man was heightened because of her memory of being abused.
In September 2023, she first encountered Henderson in the women's changing rooms.
'I looked up and saw a man. He had holes in his boxer shorts so that you could unavoidably see male genitalia.'
She had heard that a trans-identifying man was using the women's changing rooms and that she had seen Henderson before, but because of his masculine appearance, including facial hair, she had no idea that he was the individual concerned.
Danson said that Henderson asked her three times, 'Are you not getting changed yet?' and recalled that he had 'a smirk' on his face.
She said that the situation and words jolted her back to sexual abuse she experienced as a 6-year-old, when her abuser would ask her if she was 'getting changed' before bedtime.
Danson, who has previously been counselled for PTSD, said: 'Rose had the same look on his face as my Dad. I wanted to get out of there, but I couldn't.'
The nurse said she has since had nightmares about the incident, in which the face of her father replaced that of Henderson, and resorted to changing in the toilets to avoid further distressing encounters.
In March 2024, Danson and 26 other nurses sent letters to the trust outlining their concerns for their privacy, safety, and dignity in the workplace.
Health Secretary Wes Streeting leaving Downing Street, London, after a Cabinet meeting on July 9, 2024.
Lucy North/PA Wire
After five of the nurses went public last July, the trust gave the women access to a converted office to use as a 'temporary' changing room if they felt uncomfortable undressing in front of a man, and a rainbow-coloured sign labelled 'Inclusive Changing Space' was placed on the female changing room door.
The nurses took a petition with 48,000 signatures advocating for single-sex spaces to Downing Street and received widespread public support.
The NHS policy 'Transitioning in the Workplace' is used widely throughout the organisation and allows men to use women's changing facilities if they say they 'identify' as a woman, regardless of whether they are taking cross-sex hormones or have had feminising surgery.
According to the women's accounts, Henderson has said that he has a female partner who he was trying to get pregnant.
Health Secretary Wes Streeting announced last week that following the Supreme Court ruling in favour of For Women Scotland, there would be 'new rules' on matters to do with single-sex spaces issued 'within weeks.'
Interim guidance was issued by the Equality and Human Rights Commission on April 25, making clear that single-sex facilities are to be used based on biological sex only, regardless of whether or not a person has obtained a Gender Recognition Certificate.
Last October, Danson attended a meeting with Streeting where she said she told him that the changing room encounter had triggered her PTSD.
She said that while Streeting was sympathetic, no action has been taken to resolve the women's concerns, and they are still having to use the makeshift locker room, while Henderson continues to use the female changing room.
The tribunal is currently scheduled to be heard in October. Judge Stuart Robinson said the hearings will take four weeks, given that around 30 witnesses are expected to give evidence.
The nurses have filed the claim on the grounds of sexual harassment, discrimination, victimisation, and breaches of the right to a private life, under Article 8 of the European Convention on Human Rights.
A similar case is underway in Scotland, brought by nurse Sandie Peggy, who alleges she was intimidated by a trans-identifying male doctor.
The Epoch Times contacted County Durham and Darlington NHS Foundation Trust for comment.
The trust told the
The trust added: 'We want all our colleagues and patients to feel safe, respected and supported at work and in our care, [and] we are very sorry when this is not the experience. We are committed to providing a safe, compassionate environment for all patients and staff.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
38 minutes ago
- CNN
Dozens in northeast England report symptoms of potentially deadly botulism after getting Botox
Health officials in the UK are investigating reports of dozens of people suffering from a potentially life-threatening condition following Botox procedures in northeastern England, as well as allegations of the illegal sale of Botox-like products. The local trust of the UK's National Health Service (NHS) in the county of Durham put out an alert on June 13 about several people seeking medical attention after having adverse reactions to cosmetic procedures involving Botox. Since the incident first came to light last week, 28 individuals have reported symptoms of botulism after receiving cosmetic procedures, the UK Health and Security Agency (UKHSA) told CNN in a statement Friday. Botulism is a life-threatening condition caused by toxins made by Clostridium botulinum bacteria that attack the nervous system and cause paralysis. 'These toxins (but not the bacteria) are the active ingredient in Botox and similar products,' Dr. Joanne Darke, a consultant in health protection at the UKHSA, said in the statement, adding that it is 'important to go to a licensed practitioner.' Iatrogenic botulism is a type of botulism that occurs when too much of the cosmetic form, Botox, is injected into a muscle. Botox is a leading cosmetic treatment for wrinkles, as well as for medical conditions such as migraines and excessive sweating. The UKHSA said the reactions reported have included symptoms of severe drooping of the upper eyelids, double vision, difficulty swallowing, slurred speech and lethargy. Other symptoms of botulism can include facial muscle weakness. Botulism requires immediate medical attention and is fatal in 5-10% of cases, according to the NHS website. While most people make a full recovery with treatment, which typically involves getting injections with antitoxins, without quick care, paralysis can spread to muscles used to control breathing. While investigations into the cause of the cases are ongoing, the UKHSA said that 'evidence so far does not suggest that the product used has been contaminated. Symptoms are being reported a few days up to four weeks after injection.' 'The practitioners associated with most of the reported cases are no longer carrying out these procedures,' said Dr. Simon Howard, a consultant in health protection at the UKHSA, in the statement. 'However, that does not mean that we may not see more cases as symptoms can take up to four weeks to develop although we are now seeing the number of cases coming forward decreasing which is encouraging news,' he continued. Howard advised people to ensure they take precautions when seeking aesthetic procedures and advised anyone with symptoms to seek medical attention. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) told CNN Friday that it is investigating 'allegations surrounding the illegal sale and supply of Botox-type products in the North-East, and want to reassure the public that we take such claims very seriously.' The agency encouraged people in the UK who believe they have had side effects from medicine or received falsified stock to report it to its Yellow Card program. 'Our Criminal Enforcement Unit works hard to identify those involved in the illegal trade in medicines and takes robust enforcement action where necessary. This can include criminal prosecution,' Dr. Alison Cave, chief safety officer at MHRA, said in the statement. 'Botulinum toxin (Botox) is a prescription-only medicine and should only be available in the UK under the supervision of a doctor or other qualified healthcare professional,' she continued. In the United States, a growing cluster of botulism cases linked to cosmetic injections was reported in Massachusetts earlier this month. The state's Department of Health said it was investigating 10 cases of suspected iatrogenic botulism all associated with Botox procedures performed at one spa, Rodrigo Beauty.
Medscape
2 hours ago
- Medscape
ICU Skin Decolonisation May Raise Resistant Infections
Universal skin decolonisation of patients admitted to intensive care units (ICU) may not improve infection control. New research led by the University of Aberdeen indicated that it might increase meticillin-resistant Staphylococcus epidermidis (MRSE) bloodstream infections in vulnerable patients. Hospital-associated infections cause significant morbidity and mortality, with critically ill patients in ICUs at particularly high risk. Surveillance figures from English ICUs show an ICU-associated bloodstream infection rate of 3.5 per 1000 bed-days for stays of two nights or more in the year to March 2024. Over 25% of patients with these infections die within 30 days. Reasons for the increased infection rate in ICUs include high antibiotic use leading to significant skin flora colonisation by resistant bacteria. Invasive procedures including indwelling catheters and the insertion of intravascular devices are independently associated with meticillin-resistant Staphylococcus aureus (MRSA) colonisation and infection. Need for a New Infection Control Approach Decolonisation protocols were introduced in the 1990s to curb rising nosocomial MRSA infections due to MRSA. Nationwide infection control programmes since the mid-2000s led to sharp declines in MRSA rates in NHS hospitals over the next decade. One UK-wide study in ICU patients between 2007 and 2016 showed a 78% decrease in bloodstream infections overall and a 97% reduction in MRSA bloodstream infections. However, data from the National Institute for Health and Care Research show this decline plateaued after 2012. Rates have subsequently been largely static, suggesting the need for a new approach. Routine ICU decolonisation typically involves chlorhexidine skin disinfection combined with nasal mupirocin. The Aberdeen team noted conflicting evidence on chlorhexidine's effectiveness. They also raised concerns that biocide skin and mucous membrane decolonisation might lead to reduced susceptibility to chlorhexidine and selection for multidrug-resistant pathogens. Study Compares Universal and Targeted Decolonisation The researchers compared universal versus targeted skin and nasal decolonisation in ICU patients at two Scottish hospitals in adjacent health boards with different protocols. The study included patients aged 16 years and over admitted between 1 July 2009 and 28 Feb 2022. One hospital switched from universal decolonisation of all admissions to targeting only MRSA carriers from 1 February 2019. The other hospital used targeted decolonisation throughout. The researchers analysed rates of S. epidermidis bloodstream infections and tested MRSE and chlorhexidine susceptibility. Results Show Benefits in Reducing Resistant Infections The results, published in The Lancet Microbe , showed that S epidermidis was identified in 334 (45%) of 735 bloodstream infections in the hospital that de-escalated decolonisation. Of these, 197 occurred before de-escalation. Overall, bloodstream infection rates did not increase after de-escalation. However, MRSE infections declined significantly after the switch – from 10.4 to 4.3 cases per 1000 occupied bed days. The probability of MRSE among infections fell from 89.2% to 56.7%. By contrast, the control hospital reported 167 (60%) S. epidermidis bloodstream infections among 278 total, with no significant changes in infection rates or MRSE incidence. Genetic analyses revealed de-escalation was linked to fewer bloodstream infections caused by multidrug-resistant S. epidermidis strains. There was reduced carriage of mobile genetic elements and genes related to multidrug resistance and biofilm production. Balancing Benefits and Risks "In ICU settings with low MRSA incidence, the benefits of universal decolonisation should be balanced against the risks of selecting MRSE sequence types adapted for invasive and device-associated infection," the researchers concluded. Professor Karolin Hijazi, chair in oral and maxillofacial medicine at the University of Aberdeen and study lead, commented in a press release: "This research essentially demonstrates that the excess use of disinfectants in universal decolonisation offered no advantage in terms of control of serious blood infections in a low MRSA ICU setting, but instead caused the unintended rise of MRSE bloodstream infections." Implications for Infection Control Policy The authors recommended that hospitals consider the "unintended harms of universal decolonisation", especially given the global rise of antimicrobial resistance. Hijazi added that such practices increase resistance risks and costs without added benefit in low-MRSA settings. The findings should inform standardised national guidelines for effective and safe patient decolonisation, in line with the government's 5-year action plan for antimicrobial resistance, the researchers said. They described the emergence and spread of antimicrobial resistance as a 'silent pandemic' and stressed that reducing unnecessary decolonisation could help contain resistance and reduce costs.
CNN
2 hours ago
- CNN
Dozens in northeast England report symptoms of potentially deadly botulism after getting Botox
Health officials in the UK are investigating reports of dozens of people suffering from a potentially life-threatening condition following Botox procedures in northeastern England, as well as allegations of the illegal sale of Botox-like products. The local trust of the UK's National Health Service (NHS) in the county of Durham put out an alert on June 13 about several people seeking medical attention after having adverse reactions to cosmetic procedures involving Botox. Since the incident first came to light last week, 28 individuals have reported symptoms of botulism after receiving cosmetic procedures, the UK Health and Security Agency (UKHSA) told CNN in a statement Friday. Botulism is a life-threatening condition caused by toxins made by Clostridium botulinum bacteria that attack the nervous system and cause paralysis. 'These toxins (but not the bacteria) are the active ingredient in Botox and similar products,' Dr. Joanne Darke, a consultant in health protection at the UKHSA, said in the statement, adding that it is 'important to go to a licensed practitioner.' Iatrogenic botulism is a type of botulism that occurs when too much of the cosmetic form, Botox, is injected into a muscle. Botox is a leading cosmetic treatment for wrinkles, as well as for medical conditions such as migraines and excessive sweating. The UKHSA said the reactions reported have included symptoms of severe drooping of the upper eyelids, double vision, difficulty swallowing, slurred speech and lethargy. Other symptoms of botulism can include facial muscle weakness. Botulism requires immediate medical attention and is fatal in 5-10% of cases, according to the NHS website. While most people make a full recovery with treatment, which typically involves getting injections with antitoxins, without quick care, paralysis can spread to muscles used to control breathing. While investigations into the cause of the cases are ongoing, the UKHSA said that 'evidence so far does not suggest that the product used has been contaminated. Symptoms are being reported a few days up to four weeks after injection.' 'The practitioners associated with most of the reported cases are no longer carrying out these procedures,' said Dr. Simon Howard, a consultant in health protection at the UKHSA, in the statement. 'However, that does not mean that we may not see more cases as symptoms can take up to four weeks to develop although we are now seeing the number of cases coming forward decreasing which is encouraging news,' he continued. Howard advised people to ensure they take precautions when seeking aesthetic procedures and advised anyone with symptoms to seek medical attention. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) told CNN Friday that it is investigating 'allegations surrounding the illegal sale and supply of Botox-type products in the North-East, and want to reassure the public that we take such claims very seriously.' The agency encouraged people in the UK who believe they have had side effects from medicine or received falsified stock to report it to its Yellow Card program. 'Our Criminal Enforcement Unit works hard to identify those involved in the illegal trade in medicines and takes robust enforcement action where necessary. This can include criminal prosecution,' Dr. Alison Cave, chief safety officer at MHRA, said in the statement. 'Botulinum toxin (Botox) is a prescription-only medicine and should only be available in the UK under the supervision of a doctor or other qualified healthcare professional,' she continued. In the United States, a growing cluster of botulism cases linked to cosmetic injections was reported in Massachusetts earlier this month. The state's Department of Health said it was investigating 10 cases of suspected iatrogenic botulism all associated with Botox procedures performed at one spa, Rodrigo Beauty.
